Wells Fargo
MRKR icon

Wells Fargo’s Marker Therapeutics MRKR Stock Holding History

Wells Fargo’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341 Hold
232
– – ﹤0.01% 6550
2026
Q1 		$302 Sell
232
-10
-4% -$16 ﹤0.01% 6434
2025
Q4 		$361 Hold
242
– – ﹤0.01% 6357
2025
Q3 		$216 Buy
242
+10
+4% +$12 ﹤0.01% 6341
2025
Q2 		$355 Hold
232
– – ﹤0.01% 6408
2025
Q1 		$285 Hold
232
– – ﹤0.01% 6309
2024
Q4 		$722 Hold
232
– – ﹤0.01% 6288
2024
Q3 		$654 Hold
232
– – ﹤0.01% 6154
2024
Q2 		$1.26K Sell
232
-52
-18% -$221 ﹤0.01% 6074
2024
Q1 		$1.22K Buy
284
+1
+0.4% +$4 ﹤0.01% 6110
2023
Q4 		$1.56K Buy
283
+3
+1% +$10 ﹤0.01% 6138
2023
Q3 		$1.27K Buy
280
+3
+1% +$17 ﹤0.01% 6160
2023
Q2 		$859 Buy
277
+4
+1% +$7 ﹤0.01% 6353
2023
Q1 		$194 Hold
273
– – ﹤0.01% 6781
2022
Q4 		$725 Buy
273
+1
+0.4% +$3 ﹤0.01% 6281
2022
Q3 		$1K Sell
272
-1
-0.4% -$4 ﹤0.01% 6399
2022
Q2 		$1K Buy
273
+4
+1% +$13 ﹤0.01% 6554
2022
Q1 		$1K Hold
269
– – ﹤0.01% 6831
2021
Q4 		$2K Sell
269
-100
-27% -$1.33K ﹤0.01% 6898
2021
Q3 		$7K Sell
369
-3
-0.8% -$61 ﹤0.01% 6303
2021
Q2 		$10K Sell
372
-706
-65% -$18.6K ﹤0.01% 6144
2021
Q1 		$23K Sell
1,078
-4,113
-79% -$94.1K ﹤0.01% 6110
2020
Q4 		$75K Sell
5,191
-3,477
-40% -$54K ﹤0.01% 5459
2020
Q3 		$130K Sell
8,668
-394
-4% -$7.19K ﹤0.01% 5156
2020
Q2 		$188K Buy
9,062
+6,222
+219% +$136K ﹤0.01% 4946
2020
Q1 		$54K Sell
2,840
-314
-10% -$8K ﹤0.01% 5310
2019
Q4 		$91K Sell
3,154
-1,705
-35% -$62K ﹤0.01% 5341
2019
Q3 		$248K Buy
4,859
+1,716
+55% +$101K ﹤0.01% 4833
2019
Q2 		$249K Buy
+3,143
New +$187K ﹤0.01% 4845

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Wells Fargo's MRKR Position: Q2 2026 in Review

Wells Fargo held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 232 shares worth $341. The position accounts for ﹤0.01% of the portfolio, ranked #6550.

Wells Fargo first reported a position in MRKR in Q2 2019 and has held it in 29 quarters since. The position peaked at $249K in Q2 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • Wells Fargo held 232 shares of Marker Therapeutics worth $341 as of Q2 2026.
  • Wells Fargo left its Marker Therapeutics share count unchanged in Q2 2026.
  • Marker Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6550 holding.
  • Wells Fargo first reported a position in Marker Therapeutics in Q2 2019 and has held it in 29 quarters since.
  • Wells Fargo's Marker Therapeutics position peaked at $249K in Q2 2019.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.